However, this difference was lost when data were normalized to ACTA1 expression levels, a muscle differentiation marker, to take into account the loss of skeletal tissue secondary to fibrosis and impaired regeneration in DMD (Supplementary Materials, Figure S1). The gene discussed is ACTA1; the disease is Duchenne muscular dystrophy.